Aclaris Therapeutics, Inc.
Clinical trials sponsored by Aclaris Therapeutics, Inc., explained in plain language.
-
New drug shows promise for painful skin condition
Disease control CompletedThis study tested whether an experimental drug called ATI-450 could reduce painful skin lumps and improve quality of life for people with moderate-to-severe hidradenitis suppurativa. 95 participants received either the drug or a placebo for 12 weeks. Researchers measured changes …
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New skin treatment shows promise for eczema relief
Disease control CompletedThis study tested an experimental drug called ATI-2138 in 14 adults with moderate to severe atopic dermatitis (eczema) for 12 weeks. Researchers wanted to see if the drug was safe and if it could reduce skin inflammation and itching. The study measured changes in skin severity, i…
Phase: PHASE2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC